
Argo Corporation Reports Fiscal Year 2024 Financial Results
TORONTO, May 1, 2025 /CNW/ – Argo Corporation (TSXV: ARGH), (OTCQX: ARGHF) ('Argo' or the 'Company'), leader in next-generation transit solutions, announced its audited financial results for the fiscal year ended December 31, 2024. Highlights include the launch of Argo's proprietary Smart Routing™ transit system, significant growth in the revenues of FoodsUp Inc., and a successful operational transition resulting in the removal of $13 million in liabilities from its balance sheet.
In Q1 2025, the Company received approximately $2.5 million in proceeds from the sale of 5,855 subordinate-voting shares of FoodsUp Inc. All figures are in Canadian dollars unless otherwise noted.
Launch of Smart Routing™ Transit System
Argo developed and deployed the world's first fully vertically integrated Smart Routing™ transit system. This end-to-end platform combines real-time routing software, electric vehicles and full-service operations to deliver dynamic, on-demand transit services.
Research & Development: The company invested $1.5 million in research and development to build its proprietary Smart Routing™ hardware and AI-powered software ecosystem, including vertical integration hardware onboard its Argo X1 electric vehicles.
Argo Transit: In December, Argo signed a partnership with the town of Bradford West Gwillimbury to deploy the world's first vertically integrated Smart Routing™ transit system. The system is being rolled out gradually to replace the town's fixed-route bus system.
Argo School: The company successfully launched Argo School in September, which continues to serve multiple schools across Ontario with safe, on-demand student transportation.
FoodsUp Inc.
The company held a 56.386% non-controlling interest in FoodsUp Inc. as of December 31, 2024. FoodsUp is one of Canada's leading restaurant supply platforms, with annual revenues of $108 million in fiscal 2024.
Option Agreements: In Q1 2025, the Company entered into two option agreements granting the holders thereof the irrevocable option to purchase up to a total of 45,932 subordinate-voting shares of FoodsUp at a price per share of up to $658 in the coming quarters. The closing of the transactions contemplated under the option agreements is subject to any required approvals, which include approval of the TSX Venture Exchange.
Distribution Transaction: The Company continues to pursue its plan to provide its shareholders with either the net proceeds of sale of the majority of its interest in FoodsUp to a third party, or an indirect or tracking ownership interest in FoodsUp as of a to-be-determined record date. Such a distribution transaction is subject to any required approvals, including approval of the TSX Venture Exchange.
Operational Transition
The company has made significant progress in its discontinuation of legacy operations related to prior ventures of the predecessor in its corporate entity.
Sale of Assets: In Q3 2024, the company received $750,000 in proceeds for the sale of 14,200 shares of preferred stock in the capital of Westbrook Global Inc. The Company received approximately $2.5 million in proceeds from the sale of 5,855 subordinate-voting shares of FoodsUp Inc. in Q1 2025.
Reduction in Legacy Liabilities: In 2024, Argo removed $13 million in liabilities from its balance sheet related to discontinued operations in two legacy subsidiaries, which were assigned into bankruptcy under the Bankruptcy and Insolvency Act in Canada, and to an assignee for liquidation under a General Assignment for the Benefit of Creditors pursuant to California Law, respectively. These removals were completed in accordance with IFRS and reflect the full discharge of those obligations. Additionally, in Q4 2024, the company filed a statement of claim in connection with a disputed office lease, which remains as a $2.4 million liability on the balance sheet as of December 31, 2024.
For detailed information, please refer to Argo's 2024 Annual Consolidated Financial Statements and its Management Discussion and Analysis of Financial Condition and Results of Operations for the years ended December 31, 2024 and 2023 (the '2024 Annual MD&A'), filed on SEDAR+ at www.sedarplus.ca. The following table provides a summary of Argo's financial results for the years ended December 31, 2024 and 2023:
For the years ended December 31,
2024
2023
REVENUE
$1,564,865
$14,834,490
Cost of revenue
$236,091
$14,419,193
General and administration
6,560,070
3,831,910
Operational support
1,657,225
3,272,198
Research and development
1,454,184
606,765
Sales and marketing
186,324
521,852
Provision for trade and other receivables
115,207
726,112
Amortization & depreciation
383,311
1,376,311
Depreciation
56,271
704,511
Total operating expenses
10,592,412
24,754,341
OPERATING LOSS
($9,027,547)
($9,919,851)
OTHER INCOME (EXPENSES)
Government grant
–
(48,450)
Foreign exchange gain/ (loss)
(144,224)
(14,191)
Interest expenses
(2,026,312)
(278,525)
Interest income
4,000
22,734
Other expense
(538,660)
–
Loss on termination
(30,712)
–
Loss on shares for debt settlements
(90,763)
Write-off of accounts payable settlements
392,462
–
Gain/ (Loss) from the spin-off of a subsidiary
–
33,791,897
Fair value gain (loss) on investments
568,402
(919,077)
Loss on sale of investment
(159,063)
–
Gain on forgiveness of debt
114,913
Penalties and settlement
(36,671)
Derecognition of right-of-use assets
–
(2,366,016)
Share of loss of an associate
(3,842,146)
(5,737,886)
Net income/ (loss) from continuing operations
($15,208,783)
$14,530,635
Income tax recovery
Deferred income tax recovery
(129,595)
(58,761)
33,468
69,967
Discontinued Operations
Net loss from discontinued operations, net of tax
(2,724,633)
(14,224,918)
Gain from derecognition, net of tax
14,387,684
NET GAIN (LOSS)
($3,734,088)
$409,152
Cumulative translation adjustment
195,984
616,528
NET PROFIT (LOSS) AND COMPREHENSIVE PROFIT (LOSS)
($3,538,104)
$1,025,680
(Loss) Profit per share
(Loss) income per share from continuing operations – Basic and diluted
($0.12)
$0.11
Income (loss) per share from derecognition anddiscontinued operations – Basic and diluted
$0.09
($0.10)
Weighted average shares outstanding – Basic and diluted
133,586,040
132,944,615
All figures rounded to the nearest dollar. Prepared in accordance with IFRS.
About Argo
Founded in June 2024, Argo delivers the world's first fully vertically integrated transit system, combining Argo X1 electric vehicles, Smart Routing™ technology, and comprehensive operational management in a single end-to-end solution. By integrating every aspect of the transit experience, Argo enables municipalities to transition from traditional fixed-route services to dynamically optimized transit systems that deliver substantially better efficiency, coverage, and rider satisfaction while maintaining standard public transit pricing. The company launched Argo School in September 2024 and began its first municipal deployment in Bradford West Gwillimbury in early 2025. Learn more at www.rideargo.com.
Praveen Arichandran, CEOArgo Corporation(800) 575-7051
Forward-Looking Information
This news release includes certain forward-looking statements as well as management's objectives, strategies, beliefs and intentions. Forward-looking statements are frequently identified by such words as 'may', 'will', 'plan', 'expect', 'anticipate,' 'estimate,' and 'intend,' and similar words referring to future events and results. Forward-looking statements are based on the current opinions and expectations of management. The forward- looking information set out in this news release relates to future events or our future performance and includes, without limitation, statements concerning the completion of the the exercise of the options granted pursuant to the option agreements by the holders thereof, Argo's ability to obtain all necessary approvals in respect of the option agreements and the distribution transaction, and Argo's intention with respect to the distribution transaction. All forward-looking information is inherently uncertain and subject to a variety of assumptions, risks and uncertainties, as described in more detail in the Company's securities filings available at www.sedarplus.ca. Actual events or results may differ materially from those projected in the forward-looking statements, and we caution against placing undue reliance thereon. We assume no obligation to revise or update these forward-looking statements except as required by applicable law. See 'Cautionary Note Regarding Forward-Looking Information', 'Financial Risk Management Objectives And Policies' and 'Other Business Risks and Uncertainties' in the Company's 2024 Annual MD&A and its interim Management's Discussion & Analysis for the three and nine months ended September 30, 2024 for a discussion of the uncertainties, risks and assumptions associated with these statements and other risks. Readers are urged to consider the uncertainties, risks, and assumptions carefully when evaluating forward-looking information and are cautioned not to place undue reliance on such information. We have no intention and undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities legislation and regulatory requirements.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Malaysian Reserve
2 hours ago
- Malaysian Reserve
SAMSONITE TAPS BOSTON'S PAYTON PRITCHARD FOR NEW CAMPAIGN: "IT'S NOT JUST A BAG, IT'S A SAMSONITE"
The basketball standout brings his signature discipline, grit, and on-the-go lifestyle to Samsonite's latest storytelling effort — built for movement, not just travel. MANSFIELD, Mass., June 4, 2025 /PRNewswire/ — Samsonite, the iconic and trusted leader in travel gear headquartered in Massachusetts, USA, unveils its latest campaign: 'It's Not Just a Bag, It's a Samsonite.' The campaign spotlights the brand's commitment to creating expertly designed bags for all types of travel, from quick commutes to international journeys and reframes travel as a state of constant motion, where the right gear is essential to staying ready for whatever comes next. At the center of the campaign is Pritchard, whose discipline, adaptability, and quiet confidence make him a natural fit for the Samsonite ethos. Whether it's early flights, late-night practices, or showing up under pressure, his story mirrors that of today's modern traveler: focused, fast-moving, and defined by preparation. Shot across three visual chapters, Tunnel Walk, Courtside, and Travel Ready the campaign follows Pritchard through a typical day-in-motion with three distinct Samsonite collections Silhouette 18™, Proxis™, and Outline Pro®. From high-visibility style moments to focused solo downtime to the sprint toward the next destination, each scene is a nod to the different facets of travel and the products that support them. Samsonite's signature durability and iconic aesthetic are front and center, reimagined through the lens of a traveler who brings the same intensity to everyday movement as he does to game day. 'I'm always moving, always trying to stay one step ahead — and having the right travel gear with me makes a difference,' said Pritchard. 'A Samsonite isn't just a bag. It's a part of how I show up and stay ready.' David Oksman, Vice President of Marketing and Direct to Consumer at Samsonite, said, 'Travel has the power to shape us, shift perspective, and inspire new ways of seeing the world and Samsonite creates bags with that journey in mind. Payton's fast-paced lifestyle, both on and off the court, mirrors the journey of today's traveler: balancing ambition with authenticity, and movement with meaning.' The campaign's creative execution was brought to life by StudioHS and directed in partnership with Gut Feeling Production – setting out to explore and reimagine today's travel essential as a symbol of identity, resilience, and personal style. Using XR LED technology, Unreal Engine environments, and real-time motion tracking – the visuals blur the lines between physical and digital to deliver a cinematic, hyper-real world where form meets function. 'Payton is the embodiment of the modern-day utility player – versatile, dynamic, and always moving with intention,' shared Veronica Rodriguez-Greene, Chief Brand Officer and Executive Creative Director, StudioHS. 'He is not just an athlete, he's an explorer whose every move, every game, every story reflects the journey of many of today's travelers and the essence of the campaign: timeless, innovative, and quietly iconic.' Creative Team: Photographer, Bonnie Nichoalds Stylist, Derrick 'Dex' Robinson Set Designer, Natasha Nicolau XR Visual Design, Dimension 5 Production Facility, Studio Lab The campaign will roll out across digital, social, and US retail to see it across Instagram, TikTok, YouTube, and premium digital platforms, with a focus on video, vertical, and immersive storytelling. Behind-the-scenes content, campaign cutdowns, and travel-style editorials featuring Pritchard will continue to drop throughout the summer. Link to hi-res images HERELink to BTS video HERE Photo credit: Courtesy of Samsonite For more information, visit or Instagram:@samsoniteusa | Youtube:@samsonite | Tiktok:@samsoniteusa. #ItsASamsonite For media inquiries, please contactSamsonite | samsonite@ About SamsoniteFounded in 1910, Samsonite is the world leader in superior travel bags, luggage, backpacks and accessories. Samsonite builds trusted and innovative products that elevate the way we travel. Inspired by the past and built for the present, Samsonite's purpose is to pack confidence into every single journey and believes those who experience the world will move it forward. Instagram:@samsoniteusa | Youtube:@samsonite | Tiktok:@samsoniteusa


Malaysian Reserve
3 hours ago
- Malaysian Reserve
EmpiRx Health Launches New Clinical Review Messaging Solution
New Text Notification Solution Strengthens the Pharmacy Care User Experience by Keeping Members Informed in Real-Time on the Status of Their Medications' Clinical Reviews MONTVALE, N.J., June 4, 2025 /PRNewswire/ — EmpiRx Health, the leading pharmacist-led pharmacy benefits management (PBM) company, today announced the launch of a new Clinical Review Messaging solution that provides members with real-time updates on the status of their medications' clinical reviews. This innovative, easy-to-use solution elevates the overall pharmacy care experience by keeping members well informed of the approvals, partial denials, or denials of their medications during the review process. By keeping members continuously updated in real-time, the Clinical Review Messaging solution reduces confusion, enhances transparency, and fosters trust between members, clinicians, and providers. Exemplifying EmpiRx Health's deep commitment to client and member satisfaction and innovation in care delivery, Clinical Review Messaging demonstrates that behind every medication review is a collaborative and clinician-led effort to ensure the best possible patient health outcomes. Ensuring ease of use and removing barriers to access, EmpiRx Health's new Clinical Review Messaging solution makes it effortless for members to stay informed about their medication reviews, no matter where they are. Messages are delivered via SMS, so there's no need to download or learn how to use a new app. Members receive timely, important updates on their mobile phones in a simple and convenient way. 'We're excited to launch this new solution that offers members more peace of mind by helping them understand in real-time exactly where they are in the clinical review of their prescriptions,' said Kim Howland, Chief Product Officer, EmpiRx Health. 'Clinical Review Messaging is another strong example of EmpiRx Health's leadership in providing highly personalized pharmacy care that measurably improves patient health and well-being.' With regard to pricing, the Clinical Review Messaging solution is an affordable enhancement for plan sponsors looking to tangibly improve member communications and engagement. EmpiRx Health follows TCPA (Telephone Consumer Protection Act) Guidelines, with all messages being related solely to health-related items. Members must opt-in to receive text messages and can opt-out at any time. About EmpiRx Health EmpiRx Health is the leading clinically-driven, customer-first pharmacy benefits management (PBM) company that puts the pharmacist at the center of the pharmacy care model. Leveraging our AI-powered pharmacy care platform, Clinically™, EmpiRx Health's clinical pharmacists and client experience teams provide the highest quality care and service. This enables plan sponsors to measurably improve their member health outcomes while substantially reducing prescription drug costs. EmpiRx Health recently launched AllyRx, the first-ever national pharmacy care network specially designed for pharmacy and grocery retailers. With major offices in Montvale, NJ and Orlando, FL, EmpiRx Health celebrated its 10-year anniversary in 2024. To learn more, visit More information on Clinically can be found at and AllyRx at Contact For EmpiRx Health: Stephanie Cox Phone: (201)775-6971 Email: scox@


Malaysian Reserve
4 hours ago
- Malaysian Reserve
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Elevance To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Elevance between April 18, 2024 and October 16, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, June 4, 2025 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Elevance Health, Inc. ('Elevance' or the 'Company') (NYSE: ELV) and reminds investors of the July 11, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that defendants represented to investors that they were closely monitoring cost trends associated with the redetermination process and that the premium rates Elevance was negotiating with states were sufficient to address the risk and cost profiles of those patients staying on Medicaid programs. While Defendants acknowledged that Medicaid expenses were rising, they repeatedly assured investors that this was adequately reflected in the Company's guidance for the year. The truth began to emerge on July 17, 2024, when the Company revealed that it was now 'expecting second-half utilization to increase in Medicaid.' In response to this disclosure, the price of Elevance common stock declined by $32.21 per share, or 5.8%. However, Defendants continued to make false, reassuring statements to investors concerning the extent of the cost increase and how that was accounted for in the Company's full year guidance. The truth was further revealed on October 17, 2024, when Elevance announced its financial results for the third quarter of 2024, revealing that the Company had missed consensus earnings per share ('EPS') expectations for the quarter by $1.33, or 13.7%, 'due to elevated medical costs in [its] Medicaid business.' Elevance further revealed that it was lowering EPS guidance for 2024 from $37.20 to $33.00, or 11.3%, as it expected these Medicaid issues to continue. T These disclosures caused the price of Elevance common stock to decline by another $52.61 per share, or 10.6%. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding Elevance's conduct to contact the firm, including whistleblowers, former employees, shareholders and others. To learn more about the Elevance Health class action, go to or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Follow us for updates on LinkedIn, on X, or on Facebook. Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.